Iriska Pharmaceuticals Private Limited

Provides healthcare services, incorporated in 2018, based in Hapur, Uttar Pradesh.

2018 | Ghaziabad, Uttar Pradesh (India) | Active
Last Updated:

Iriska Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 286.79%
  • Profit Growth 862.02%
  • Ebitda 130.36%
  • Net Worth 10.84%
  • Total Assets 79.34%

About Iriska Pharmaceuticals

Iriska Pharmaceuticals Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 April 2018 (Seven years and one month 25 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Priyanka Sharma and Rahul Yadav serve as directors at the Company.

Company Details

  • Location

    Ghaziabad, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74999UP2018PTC103206

  • Company No.

    103206

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 Apr 2018

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Industry

Healthcare

What products or services does Iriska Pharmaceuticals Private Limited offer?

Iriska Pharmaceuticals Private Limited offers a wide range of products and services, including Immunity Boosters, Vitamin C, Vitamins & Supplements, Mineral Supplements.

Company report

Iriska Pharmaceuticals Private Limited

Explore comprehensive data for Iriska Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Iriska Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Priyanka Sharma Country flag representing In Director 16-Apr-2018Current
Rahul Yadav Country flag representing In Director 16-Apr-2018Current

Financial Performance of Iriska Pharmaceuticals.

Iriska Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 286.79% increase. The company also saw a substantial improvement in profitability, with a 862.02% increase in profit. The company's net worth Soared by an impressive increase of 10.84%.

Iriska Pharmaceuticals revenue growth over time
Iriska Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
286.79%
Revenue from Operations
286.79%
Total Assets
79.34%
Profit or Loss
862.02%
Net Worth
10.84%
EBITDA
130.36%

What is the Ownership and Shareholding Structure of Iriska Pharmaceuticals?

Unlock access to Iriska Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Iriska Pharmaceuticals?

Unlock and access historical data on people associated with Iriska Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Iriska Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Iriska Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iriska Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Iriska Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Iriska Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Iriska Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.

  • Director Appointment

    Priyanka Sharma was appointed as a Director was appointed as a Director on 16 Apr 2018 & has been associated with this company since 7 years 1 month .

  • Director Appointment

    Rahul Yadav was appointed as a Director was appointed as a Director on 16 Apr 2018 & has been associated with this company since 7 years 1 month .

  • Company Incorporation

    Iriska Pharmaceuticals Private Limited was registered on 16 Apr 2018 with Roc Kanpur & aged 7 years 1 month as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Iriska Pharmaceuticals Private Limited?

    Iriska Pharmaceuticals Private Limited was incorporated on 16 Apr 2018.

  • What is authorized share capital and paid-up capital of Iriska Pharmaceuticals Private Limited?

    The authorized share capital of Iriska Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Iriska Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Iriska Pharmaceuticals Private Limited.

    • Priyanka Sharma
    • Rahul Yadav
  • What is the registered address of Iriska Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Iriska Pharmaceuticals Private Limited is Shop No. 4 First Floor City Plaza Gandhi Bazar, Pilkhuwa India, District Hapur, Uttar Pradesh, 245304.

  • What is the corporate identification number (CIN) and company number of Iriska Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Iriska Pharmaceuticals Private Limited is U74999UP2018PTC103206 and the company number is 103206 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Iriska Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2020, the revenue trend for Iriska Pharmaceuticals Private Limited has risen by 286.79%.

  • What change has been observed in the net worth of Iriska Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Iriska Pharmaceuticals Private Limited has experienced an upsurge of 10.84%.

  • When was the last Balance Sheet of Iriska Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Iriska Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial